Colorectal Cancer Screening
Recently Published Documents


TOTAL DOCUMENTS

5274
(FIVE YEARS 2243)

H-INDEX

98
(FIVE YEARS 32)

2021 ◽  
Vol 4 (12) ◽  
pp. e2136798
Author(s):  
A. Mark Fendrick ◽  
Nicole Princic ◽  
Lesley-Ann Miller-Wilson ◽  
Kathleen Wilson ◽  
Paul Limburg

Author(s):  
SW Tay ◽  
KKJ Teh ◽  
TL Ang ◽  
M Tan

The landscape of ulcerative colitis has changed in the last two decades. Advancements in pharmacotherapeutics have heralded the introduction of new treatment options, with many agents in development. Better clinical outcomes are seen with tighter disease control, made possible with greater understanding of inflammatory pathways and their blockade with drugs. There has been a resultant shift in treatment targets, beyond symptoms to endoscopic and histological healing. Controlling the burden of disease activity also lowers the risk of developing colorectal cancer. Colorectal cancer screening now requires the use of dye-based agents and high definition colonoscopy to improve detection of colonic neoplasms.


2021 ◽  
pp. 096914132110569
Author(s):  
Gavin RC Clark ◽  
Jayne Digby ◽  
Callum G Fraser ◽  
Judith A Strachan ◽  
Robert JC Steele

Objective There is evidence that colorectal cancer screening using faecal haemoglobin is less effective in women than men. The faecal haemoglobin concentrations were therefore examined in women and men with screen-detected colorectal cancer. Setting Scottish Bowel Screening Programme, following the introduction of a faecal immunochemical test from November 2017, to March 2020. Methods Data were collated on faecal haemoglobin concentrations, pathological stage and anatomical site of the main lesion in participants who had colorectal cancer detected. The data in women and men were compared. Results For the faecal haemoglobin concentrations studied (>80 µg Hb/g faeces), the distributions indicated lower concentrations in women. Marked differences were found between women and men diagnosed with colorectal cancer. The median faecal haemoglobin concentration for women ( n = 720) was 408 µg Hb/g faeces compared to 473 µg Hb/g faeces for men ( n = 959) ( p = 0.004) and 50.6% of the results were >400 µg Hb/g faeces in women; in men, this was 57.8%. The difference in faecal haemoglobin concentrations in women and men became less statistically significant as stage advanced from stages I–IV. For right-sided, left-sided and rectal colorectal cancer, a similar gender difference persisted in all sites. Differences in faecal haemoglobin between the genders were significant for left-sided cancers and stage I and approached significance for rectal cancers and stage II, but all sites and stages showed lower median faecal haemoglobin concentrations for women. Conclusions To minimise gender inequalities, faecal immunochemical test-based colorectal cancer screening programmes should evaluate a strategy of using different faecal haemoglobin concentration thresholds in women and men.


Author(s):  
Caitlin C. Murphy ◽  
Ethan A. Halm ◽  
Timothy Zaki ◽  
Carmen Johnson ◽  
Sruthi Yekkaluri ◽  
...  

Pathogens ◽  
2021 ◽  
Vol 10 (11) ◽  
pp. 1508
Author(s):  
Suneha Sundaram ◽  
Sean Olson ◽  
Paranjay Sharma ◽  
Shanmugarajah Rajendra

The COVID-19 pandemic has impacted all aspects of medical care, including cancer screening and preventative measures. Colorectal cancer screening declined significantly at the onset of the pandemic as the result of an intentional effort to conserve resources, prioritize emergencies and reduce risk of transmission. There has already been an increase in diagnosis at more advanced stages and symptomatic emergencies due to suspended screenings. As endoscopy units find their way back to pre-pandemic practices, a backlog of cases remains. The missed CRC diagnoses amongst the missed screenings carry a risk of increased morbidity and mortality which will only increase as time-to-diagnosis grows. This review discusses the impact of COVID-19 on colonoscopy screening rates, trends in stages/symptoms/circumstances at diagnosis, and economic and social impact of delayed diagnosis. Triaging and use of FITs are proposed solutions to the challenge of catching up with the large number of pandemic-driven missed CRC screenings.


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Robert Babela ◽  
Andrej Orsagh ◽  
Jana Ricova ◽  
Iris Lansdorp-Vogelaar ◽  
Marcell Csanadi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document